Bal Pharma Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 88.88 | 83.70 | 87.84 |
| Operating Expense | 80.48 | 73.29 | 77.82 |
| Net Profit | 1.16 | 3.70 | 1.95 |
| Net Profit Margin | 1.31% | 4.42% | 2.22% |
| Earning Per Share | 0.73 | 2.60 | 1.22 |
| EBIDTA | 8.41 | 10.79 | 10.03 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Jun 2026
Revenue88.88
Operating Expense80.48
Net Profit1.16
Net Profit Margin1.31
Earning Per Share0.73
EBIDTA8.41
Effective Tax Rate0
